{"id":"W2157759118","doi":"10.1212/wnl.0b013e3182698c64","title":"Disease-modifying drugs for multiple sclerosis in pregnancy","year":2012,"lang":"en","type":"review","venue":"Neurology","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":160,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Schweizerische Multiple Sklerose Gesellschaft; Multiple Sclerosis Trust; Multiple Sclerosis Society of Canada; Biogen; Michael Smith Health Research BC; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; University of British Columbia; Multiple Sclerosis Society","keywords":"Glatiramer acetate; Medicine; Natalizumab; Pregnancy; Fingolimod; Birth weight; Obstetrics; Low birth weight; Pediatrics; Discontinuation; Cohort study; Multiple sclerosis; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003302095,0.0005551487,0.001902844,0.0003263818,0.0001371566,0.0000107006,0.0004906604,0.0009293851,0.0001172356],"category_scores_gemma":[0.0002152971,0.000468682,0.0005948327,0.0002081575,0.0001691339,0.00009900804,0.0001748144,0.0007024198,0.0006867362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003627439,"about_ca_system_score_gemma":0.0001437979,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004351046,"about_ca_topic_score_gemma":0.00001813758,"domain_scores_codex":[0.9960894,0.001109524,0.0008040498,0.001069367,0.00003312491,0.0008945177],"domain_scores_gemma":[0.9976736,0.0008928622,0.0004368475,0.0008910396,0.00004963732,0.00005602516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001268778,0.0001819028,0.001280827,0.01332556,0.0001788786,0.000009341351,0.0001740854,6.080347e-7,0.00003440551,0.0003170784,0.0002745031,0.9840959],"study_design_scores_gemma":[0.0009637494,0.0001710697,0.000749391,0.006274582,0.0005111857,0.00005117158,0.000002175119,1.912799e-7,0.000006902227,0.00007682074,0.990794,0.0003987846],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007619616,0.9926051,0.00003064459,0.00006349869,0.00370219,0.002847076,0.0002335885,0.000086764,0.0003548901],"genre_scores_gemma":[0.005207981,0.9909179,0.00001808692,0.00006899293,0.0002216108,0.002313209,0.0004329531,0.0001056458,0.000713574],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9905195,"threshold_uncertainty_score":0.9997765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1268651751819757,"score_gpt":0.3089392886387552,"score_spread":0.1820741134567796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}